StockData
MASSNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31

908 Devices Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$11.43+0.17 (+1.51%)

Close on Oct 19, 2026

Market cap
$431.23M
P/E (TTM)
–
Dividend yield
–

908 Devices Inc. revenue by segment

By business segment

By product or service

RevenueTTM Q2 26TTM Q1 26TTM Q4 25TTM Q3 25TTM Q2 25TTM Q1 25TTM Q4 24TTM Q3 24TTM Q2 24TTM Q1 24TTM Q4 23TTM Q3 23% of revenueYoY
Product revenue$48.89M$45.49M$43.28M$39.48M$39.86M$38.83M$35.53M$36.43M$37.38M$38.42M$40.21M$37.11M80.4%+22.7%
Device sales revenue$41.35M$38.61M$36.66M$34.08M$35.02M$34.51M$31.69M$32.04M$32.70M$32.89M$33.38M$28.28M68.0%+18.1%
Recurring revenue$19.33M$19.12M$19.42M$18.86M$18.44M$17.40M$15.93M$15.68M$14.84M$15.13M$16.48M$17.63M31.8%+4.8%
Service and contract revenue$11.95M$12.31M$12.92M$13.68M$13.82M$13.27M$12.22M$11.69M$10.53M$9.97M$10.02M$8.80M19.6%-13.5%
Product and service revenue––––––$59.63M$55.39M$52.96M$50.96M$50.23M$45.91M––
Contract revenue––$117.00K$228.00K$215.00K$295.00K$132.00K–––$370.00K$1.61M––

By region

RevenueTTM Q2 26TTM Q1 26TTM Q4 25TTM Q3 25TTM Q2 25TTM Q1 25TTM Q4 24TTM Q3 24TTM Q2 24TTM Q1 24TTM Q4 23TTM Q3 23% of revenueYoY
United States$45.75M$44.84M$41.25M$36.96M$38.23M$36.64M$35.65M$39.27M$39.18M$37.69M$38.17M$36.45M75.2%+19.7%
Europe, Middle East and Africa$8.04M$7.10M$10.43M$11.89M$12.10M$12.59M$9.13M$6.58M$6.29M$8.39M$9.38M$8.73M13.2%-33.6%
Asia Pacific$4.27M$3.40M$3.00M$3.31M$2.59M$2.17M$2.10M$1.07M$1.39M$1.36M$1.83M$1.81M7.0%+64.7%
Americas other$2.79M$2.47M$1.53M$997.00K$755.00K$701.00K$863.00K$840.00K$669.00K$717.00K$853.00K$536.00K4.6%+268.9%

From the segment and revenue-disaggregation notes of 908 Devices's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.